Robust Neutralizing Antibodies to SARS-CoV-2 Develop and Persist in Subjects with Diabetes and COVID-19 Pneumonia.
J Clin Endocrinol Metab
; 106(5): 1472-1481, 2021 04 23.
Article
in En
| MEDLINE
| ID: mdl-33513242
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Pneumonia
/
Diabetes Complications
/
Antibodies, Neutralizing
/
COVID-19
Limits:
Female
/
Humans
/
Male
Language:
En
Journal:
J Clin Endocrinol Metab
Year:
2021
Document type:
Article
Affiliation country:
Italia
Country of publication:
Estados Unidos